Andreas Reiff

Background

About Andreas Reiff

Physician scientist, business executive, entrepreneur, and consultant. Multiple roles as a Chief Medical Officer for Neutrolis and TheraKine and as Senior Vice President, and global therapeutic area head for inflammation and immunology at Parexel International. Additionally, long tenure as a clinician, faculty member, and researcher at various academic medical centers. Expertise includes the treatment and management of autoimmune diseases (AIDs), treatment of inflammatory and degenerative eye diseases, and alternatives to stem cell transplantation for the treatment of AIDs. Physician/Scientist: Recognized international thought leader and speaker on biologic drug development and the treatment of chronic inflammatory eye diseases. Authored/co-authored numerous journal articles, abstracts, reviews, and book chapters. Served as PI and co-investigator on numerous clinical trials in immunology and inflammation. Business Growth Leader: As SVP at Parexel, more than doubled NBA of this franchise since inception. Consulting: Advisor to top biopharma firms, including Immunex, Wyeth, Amgen, Merck, Abbott/AbbVie, Pfizer, Novartis, Genentech, Regeneron/Sanofi, and Bristol Meyer Squibb. Entrepreneur: Founder and CMO of TheraKine, a biotech start-up that developed and patented a fully biodegradable sustained release delivery platform for the local application of biologic agents and small molecules.